In 2016 the company secured €3m in funding from the EU to support the final stage of development of a natural ingredient which the company says will prevent diabetes developing.
The funding will include Irish-based clinical trials which will take place over the next 18 months. If the trials are successful and the product gains approval, the new “peptide” could be used in food products across the EU by 2020.
.jpg)



